Earnings

Concentrix Narrows FY2026 Adj EPS Guidance from $10.83-$11.18 to $10.97-$11.09 vs $11.38 Est; Lowers FY2026 Sales Guidance from $9.925B-$10.025B to $9.827B-$9.877B vs $10.015B Est

Sep 29, 2026 · 04:07 PM ET· updated 1h ago

Concentrix (NASDAQ:CNXC) narrows FY2026 Adj EPS guidance from $10.83-$11.18 to $10.97-$11.09 vs $11.38 analyst estimate. Lowers FY2026 sales outlook from $9.925 billion-$10.025 billion to $9.827 billion-$9.877 billion

Why It Matters

Concentrix told investors it expects to make less money next year than planned. When a company lowers its own forecast, watch whether it can turn things around.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

CNXC22.45

-3.00 (-11.78%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.